FI925849A - Tiazolidinfoereningar, deras framstaellning och terapeutiska anvaendningar - Google Patents

Tiazolidinfoereningar, deras framstaellning och terapeutiska anvaendningar Download PDF

Info

Publication number
FI925849A
FI925849A FI925849A FI925849A FI925849A FI 925849 A FI925849 A FI 925849A FI 925849 A FI925849 A FI 925849A FI 925849 A FI925849 A FI 925849A FI 925849 A FI925849 A FI 925849A
Authority
FI
Finland
Prior art keywords
alkyl
hydrogen
thiazolidinfoereningar
terapeutiska
anvaendningar
Prior art date
Application number
FI925849A
Other languages
English (en)
Finnish (fi)
Other versions
FI925849A0 (fi
Inventor
Takao Yoshioka
Takahide Nishi
Tsutomu Kanai
Yuichi Aizawa
Kunio Wada
Takashi Fujita
Hiroyoshi Horikoshi
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of FI925849A0 publication Critical patent/FI925849A0/fi
Publication of FI925849A publication Critical patent/FI925849A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI925849A 1991-12-26 1992-12-23 Tiazolidinfoereningar, deras framstaellning och terapeutiska anvaendningar FI925849A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP34457191 1991-12-26

Publications (2)

Publication Number Publication Date
FI925849A0 FI925849A0 (fi) 1992-12-23
FI925849A true FI925849A (fi) 1993-06-27

Family

ID=18370304

Family Applications (1)

Application Number Title Priority Date Filing Date
FI925849A FI925849A (fi) 1991-12-26 1992-12-23 Tiazolidinfoereningar, deras framstaellning och terapeutiska anvaendningar

Country Status (21)

Country Link
EP (1) EP0549365B1 (xx)
JP (1) JP2833949B2 (xx)
CN (1) CN1032751C (xx)
AT (1) ATE126221T1 (xx)
AU (1) AU654223B2 (xx)
CA (1) CA2086277A1 (xx)
CZ (1) CZ389792A3 (xx)
DE (1) DE69204041T2 (xx)
DK (1) DK0549365T3 (xx)
ES (1) ES2078671T3 (xx)
FI (1) FI925849A (xx)
GR (1) GR3017632T3 (xx)
HK (1) HK196095A (xx)
HU (1) HU215450B (xx)
IL (1) IL104238A (xx)
MX (1) MX9207595A (xx)
NO (1) NO302471B1 (xx)
NZ (1) NZ245612A (xx)
RU (1) RU2095354C1 (xx)
TW (1) TW211007B (xx)
ZA (1) ZA9210021B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO302519B1 (no) * 1991-12-26 1998-03-16 Sankyo Co Tiazolidinforbindelser som inneholder en kinongruppe, og farmasöytisk preparat
EP0783888A1 (en) 1995-12-26 1997-07-16 Sankyo Company Limited Use of troglitazone and related thiazolidinediones in the manufacture of a medicament for the treatment and prophylaxis of osteoporosis
US6331633B1 (en) * 1998-05-08 2001-12-18 Calyx Therapeutics Inc. Heterocyclic analogs of diphenylethylene compounds
EP1148054B1 (en) * 2000-04-21 2005-11-23 Pfizer Products Inc. Thyroid receptor ligands
US6620830B2 (en) 2000-04-21 2003-09-16 Pfizer, Inc. Thyroid receptor ligands
AU2001259130A1 (en) * 2000-04-24 2001-11-07 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
US6680387B2 (en) 2000-04-24 2004-01-20 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
US6768008B2 (en) 2000-04-24 2004-07-27 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
JP2003040877A (ja) * 2001-07-24 2003-02-13 Sumika Fine Chemicals Co Ltd 5−[6−(2−フルオロベンジルオキシ)−2−ナフチル]メチル−2,4−チアゾリジンジオンの製造方法及びその精製方法
CN101454005B (zh) 2006-03-16 2013-01-02 新陈代谢解决方案开发公司 用于治疗代谢性炎症介导的疾病的噻唑烷二酮类似物
CA2646149A1 (en) 2006-03-16 2007-09-27 Metabolic Solutions Development Company Thiazolidinedione analogues for the treatment of hypertension and for lowering lipids
US8304441B2 (en) 2007-09-14 2012-11-06 Metabolic Solutions Development Company, Llc Thiazolidinedione analogues for the treatment of metabolic diseases
ES2398313T3 (es) * 2007-09-14 2013-03-15 Metabolic Solutions Development Company Llc 5-(4-(2-(3-metoxifenil)-2-oxoetoxi)bencil)tiazolidin-2,4-diona para uso en el tratamiento de la diabetes
WO2011084453A1 (en) 2009-12-15 2011-07-14 Metabolic Solutions Development Company Ppar-sparing thiazolidinedione salts for the treatment of metabolic diseases
CA2796437C (en) * 2010-04-19 2018-09-11 Metabolic Solutions Development Company, Llc Novel synthesis for thiazolidinedione compounds
MX2012012095A (es) * 2010-04-21 2012-12-17 Metabolic Solutions Dev Co Llc Analogos de tiazolidinadiona.
ES2609837T3 (es) 2010-08-10 2017-04-24 Octeta Therapeutics, Llc Nueva síntesis de compuestos de tiazolidindiona
CN115433144B (zh) * 2022-10-09 2023-09-19 燃点(南京)生物医药科技有限公司 一种脂肪酸酯类化合物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US5143930A (en) * 1990-02-07 1992-09-01 Sankyo Company, Limited Thiazolidine derivatives with anti-diabetic activity, their preparation and their use
NO302519B1 (no) * 1991-12-26 1998-03-16 Sankyo Co Tiazolidinforbindelser som inneholder en kinongruppe, og farmasöytisk preparat

Also Published As

Publication number Publication date
JP2833949B2 (ja) 1998-12-09
NO924964D0 (no) 1992-12-22
ES2078671T3 (es) 1995-12-16
NO924964L (no) 1993-06-28
NO302471B1 (no) 1998-03-09
FI925849A0 (fi) 1992-12-23
JPH05239041A (ja) 1993-09-17
RU2095354C1 (ru) 1997-11-10
MX9207595A (es) 1994-06-30
EP0549365B1 (en) 1995-08-09
DK0549365T3 (da) 1995-12-18
CN1074680A (zh) 1993-07-28
HU215450B (hu) 1999-04-28
DE69204041D1 (de) 1995-09-14
CA2086277A1 (en) 1993-06-27
AU3043192A (en) 1993-07-01
CN1032751C (zh) 1996-09-11
GR3017632T3 (en) 1996-01-31
CZ389792A3 (en) 1994-01-19
HK196095A (en) 1996-01-05
HUT67788A (en) 1995-04-28
NZ245612A (en) 1994-06-27
EP0549365A1 (en) 1993-06-30
ZA9210021B (en) 1993-07-02
ATE126221T1 (de) 1995-08-15
IL104238A (en) 1996-10-31
AU654223B2 (en) 1994-10-27
TW211007B (xx) 1993-08-11
HU9204130D0 (en) 1993-04-28
DE69204041T2 (de) 1996-03-28

Similar Documents

Publication Publication Date Title
FI925849A0 (fi) Tiazolidinfoereningar, deras framstaellning och terapeutiska anvaendningar
FI925848A0 (fi) Tizolidinfoereningar, som innehaoller en kinogrupp, deras framstaellning och terapeutiska anvaendningar
FI910034A (fi) 3-aminopiperidinderivat och liknande kvaeve innehaollande heterocykler.
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
ES551274A0 (es) Un procedimiento para la sintesis de derivados de imidazol.
RU92016231A (ru) Тиазолидиновые соединения, способ их получения, фармацевтическая композиция и способ лечения
RU92016230A (ru) Тиазолидиновые соединения, фармацевтическая композиция, способ лечения и способы получения соединений
DE3670480D1 (de) Insektizide alkene.
FI20021652A (fi) Tratsodonin alkyylijohdannaisten valmistuksessa käyttökelpoisia välituotteita
FI930092A (fi) Indanopyrrolidinkarbamater
ES2143159T3 (es) Nuevos derivados de 2-ciano-3-hidroxi-propenamidas que comprenden un radical trifluorometilsulfonilfenilo/trifluorometilsulfinilfenilo, procedimiento de preparacion, aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
ES2044883T3 (es) Procedimiento para preparar quinoxalinas sustituidas.
FI943360A (fi) Propoksibentseenijohdannaisia
ES8304998A1 (es) "procedimiento para preparar derivados fenetilados de tiazol".

Legal Events

Date Code Title Description
FD Application lapsed